Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer (Q40003162)

16 September 2017

title

Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer (English)

1 reference

16 September 2017

1 reference

Hidekazu Koike

1

1 reference

16 September 2017

Yoshitaka Sekine

2

1 reference

16 September 2017

Makoto Kamiya

3

1 reference

16 September 2017

Haruki Nakazato

4

1 reference

16 September 2017

Kazuhiro Suzuki

5

1 reference

16 September 2017

language of work or name

English

0 references

publication date

12 March 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

72

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

1229-1233

1 reference

Survivin as a target for new anticancer interventions

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Survivin splice variants regulate the balance between proliferation and cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Transcriptional expression of survivin and its splice variants in cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Cancer gene therapy using a survivin mutant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

RNA interference is mediated by 21- and 22-nucleotide RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Short interfering RNAs as a tool for cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

10.1016/J.UROLOGY.2007.12.064

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference